Compare CSTL & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CSTL | CNOB |
|---|---|---|
| Founded | 2007 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2019 | 1996 |
| Metric | CSTL | CNOB |
|---|---|---|
| Price | $32.44 | $27.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $46.67 | $30.00 |
| AVG Volume (30 Days) | ★ 407.5K | 285.9K |
| Earning Date | 02-26-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.63 |
| Revenue | ★ $343,530,000.00 | $341,316,000.00 |
| Revenue This Year | $2.88 | $38.80 |
| Revenue Next Year | N/A | $7.49 |
| P/E Ratio | ★ N/A | $17.04 |
| Revenue Growth | 10.15 | ★ 36.38 |
| 52 Week Low | $14.59 | $20.61 |
| 52 Week High | $44.28 | $29.28 |
| Indicator | CSTL | CNOB |
|---|---|---|
| Relative Strength Index (RSI) | 24.66 | 58.72 |
| Support Level | $38.20 | $27.37 |
| Resistance Level | $40.88 | $28.40 |
| Average True Range (ATR) | 1.98 | 0.91 |
| MACD | -1.10 | 0.00 |
| Stochastic Oscillator | 3.79 | 62.42 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.